Cipta Sarana Medika Tbk. vs WIR ASIA Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while WIR ASIA Tbk. trades at Rp53 (market cap 620.81B, 28.91M 24h volume). The key difference: WIR ASIA Tbk. is far larger — about 3.9× Cipta Sarana Medika Tbk.'s market cap, and WIR ASIA Tbk. is more actively traded (28.91M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | WIRG | |
|---|---|---|
Market Cap | 158.12B | 620.81B |
Volume | 8.21M | 28.91M |
Lot | 82.15K | 289.05K |
Turnover | 515.2M | 1.51B |
Average Price | 62.72 | 52.37 |
Value | 515.2M | 1.51B |
Indicative Equilibrium Price | 63 | 53 |
Indicative Equilibrium Volume | 1.33K | 11.94K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.
Read more on WIRG →